Orphapacket:
  AverageAgeOfOnsets:
    AverageAgeOfOnset:
    - value: All ages
  DisorderType:
    PURL: http://www.orpha.net/ORDO/Orphanet_377789
    value: Malformation syndrome
  Label: Myalgia-eosinophilia syndrome associated with tryptophan
  ORPHAcode: '2582'
  ORPHApacketId: '2582'
  PURL: http://www.orpha.net/ORDO/Orphanet_2582
  Parents:
  - Parent:
    - Label: Rare systemic disease
      ORPHAcode: '182222'
  Phenotypes:
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001025
      HPOTerm: Urticaria
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001072
      HPOTerm: Thickened skin
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001369
      HPOTerm: Arthritis
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001376
      HPOTerm: Limitation of joint mobility
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0001880
      HPOTerm: Eosinophilia
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001888
      HPOTerm: Lymphopenia
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002103
      HPOTerm: Abnormality of the pleura
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0003011
      HPOTerm: Abnormality of the musculature
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0005469
      HPOTerm: Flat occiput
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0007328
      HPOTerm: Impaired pain sensation
  Prevalences:
    Prevalence:
    - PrevalenceClass: Unknown
      PrevalenceGeographic: Worldwide
      PrevalenceQualification: Class only
      PrevalenceType: Point prevalence
      Source: ORPHANET_21702023[PMID]
      ValMoy: '0.0'
  TextSection:
    Contents: Myalgia-eosinophilia syndrome associated with tryptophan is a rare systemic
      disease characterized by severe myalgia and peripheral eosinophilia associated
      with tryptophan dietary supplementation. The symptoms do not subside after tryptophan
      discontinuation. Clinical presentation includes muscle tenderness and cramps
      fatigue weakness paresthesia peripheral edema arthralgia dyspnea skin rash dry
      mouth and development of scleroderma-like skin abnormalities.
    TextSectionType: Definition
  TypeOfInheritances:
    TypeOfInheritance:
    - value: Not applicable
  copyright: Orphanet (c) 2023
  creationDate: '2023-12-06 11:51:54'
  version: 1.3.29 / 4.1.7 [2023-08-02] (orientdb version)
